Skip to search formSkip to main contentSkip to account menu

Baculovirus CEA Protein Vaccine

Known as: CEA Vaccine 
A vaccine consisting of recombinant carcinoembryonic antigen (CEA) produced by a baculovirus expression system with potential antineoplastic activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A phase I trial of a recombinant CEA yeast-based vaccine targeting CEA-expressing cancers.
458 Background: Saccharomyces cerevisiae (yeast) has been genetically modified to express CEA protein and employed as a heat… 
2007
2007
Vaccination of CEA-transgenic mice with a recombinant Saccharomyces cerevisiae-CEA vaccine breaks immune tolerance and elicits therapeutic antitumor responses
A104 Studies were designed to determine if vaccination of human carcinoembryonic antigen (CEA)-transgenic mice (where CEA is a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)